The Path from Biomarker Discovery to Regulatory Qualification is a unique guide that focuses on biomarker qualification, its history and current regulatory settings in both the US and abroad. This multi-contributed book provides a detailed look at the next step to developing biomarkers for clinical use and covers overall concepts, challenges, strategies and solutions based on the experiences of regulatory authorities and scientists. Members of the regulatory, pharmaceutical and biomarker development communities will benefit the most from using this book-it is a complete and practical guide to biomarker qualification, providing valuable insight to an ever-evolving and important area of regulatory science. For complimentary access to chapter 13, 'Classic' Biomarkers of Liver Injury, by John R. Senior, Associate Director for Science, Food and Drug Administration, Silver Spring, Maryland, USA, please visit the following site: http://tinyurl.com/ClassicBiomarkers
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
PhD, Vice President, Strategic Regulatory Intelligence, Vertex Pharmaceuticals, Cambridge, MA
William B. Mattes, PhD, DABT, Senior Director of COPD Biomarkers Qualification Consortium, COPD Foundation and Founder and Principal, PharmPoint Consulting
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. pp. 208 3:B&W 7.5 x 9.25 in or 235 x 191 mm Perfect Bound on White w/Gloss Lam. Artikel-Nr. 57083266
Anzahl: 3 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Artikel-Nr. ria9780123914965_new
Anzahl: Mehr als 20 verfügbar
Anbieter: moluna, Greven, Deutschland
Kartoniert / Broschiert. Zustand: New. Contains a collection of experiences of different groups taking different types of biomarkers to different levels of qualification and provides insightful case studies of an important area of regulatory science Focuses on practical advice,. Artikel-Nr. 5891063
Anzahl: Mehr als 20 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - With the evolution of translational and personalized medicine, there is growing excitement surrounding the use of biomarkers as an important tool to increase efficiency in drug discovery. The reality, however, is that without biomarker qualification or regulatory approval, scientists are unable to use the biomarker to support drug registration. The Path from Biomarker Discovery to Regulatory Qualification is a collection of experiences, challenges and outcomes from different groups worldwide who have been involved in biomarker qualification. Each chapter will focus on overall concepts, strategies and outcomes, providing those individuals in the regulatory, pharmaceutical and biomarker development communities with an insightful and practical guide to biomarker qualification. Artikel-Nr. 9780123914965
Anzahl: 2 verfügbar